- Home
- SSBK vs GEVO Comparison
SSBK vs GEVO Comparison
Compare SSBK & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSBK
- GEVO
- Stock Information
- Founded
- SSBK 2007
- GEVO 2005
- Country
- SSBK United States
- GEVO United States
- Employees
- SSBK N/A
- GEVO N/A
- Industry
- SSBK Commercial Banks
- GEVO Major Chemicals
- Sector
- SSBK Finance
- GEVO Industrials
- Exchange
- SSBK Nasdaq
- GEVO Nasdaq
- Market Cap
- SSBK N/A
- GEVO 285.1M
- IPO Year
- SSBK 2021
- GEVO 2011
- Fundamental
- Price
- SSBK $35.53
- GEVO $1.14
- Analyst Decision
- SSBK Buy
- GEVO Buy
- Analyst Count
- SSBK 1
- GEVO 2
- Target Price
- SSBK $36.00
- GEVO $7.58
- AVG Volume (30 Days)
- SSBK 41.8K
- GEVO 2.4M
- Earning Date
- SSBK 04-21-2025
- GEVO 05-13-2025
- Dividend Yield
- SSBK 1.01%
- GEVO N/A
- EPS Growth
- SSBK 6.02
- GEVO N/A
- EPS
- SSBK 3.80
- GEVO N/A
- Revenue
- SSBK $99,026,000.00
- GEVO $16,915,000.00
- Revenue This Year
- SSBK $19.18
- GEVO $617.82
- Revenue Next Year
- SSBK $7.05
- GEVO $84.22
- P/E Ratio
- SSBK $9.36
- GEVO N/A
- Revenue Growth
- SSBK 18.43
- GEVO N/A
- 52 Week Low
- SSBK $24.86
- GEVO $0.48
- 52 Week High
- SSBK $39.16
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- SSBK 63.53
- GEVO 49.70
- Support Level
- SSBK $34.44
- GEVO $1.00
- Resistance Level
- SSBK $35.37
- GEVO $1.14
- Average True Range (ATR)
- SSBK 0.74
- GEVO 0.08
- MACD
- SSBK 0.28
- GEVO 0.00
- Stochastic Oscillator
- SSBK 93.37
- GEVO 60.87
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.